SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10QSB - Optional form for quarterly and transition reports of small business issuers:
SEC Accession No. 0001169232-05-004308
Filing Date
2005-08-23
Accepted
2005-08-23 17:05:03
Documents
5
Period of Report
2005-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT d65044_10qsb.htm 10QSB 660313
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER d65044_ex31-1.htm EX-31.1 8605
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER d65044_ex31-2.htm EX-31.2 8599
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER d65044_ex32-1.htm EX-32.1 4649
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER d65044_ex32-2.htm EX-32.2 4831
  Complete submission text file 0001169232-05-004308.txt   688509
Mailing Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10QSB | Act: 34 | File No.: 000-50590 | Film No.: 051044175
SIC: 2834 Pharmaceutical Preparations